TSUMURA Top
ABOUT KAMPO
Kampo medicine has been highly expected more and more in the modern medicine
It has developed in its own way by adapting to the climate and culture of Japan and the constitution of the Japanese people, and has become a traditional Japanese medicine.
AT A GLANCE
Creating new value through innovations in Kampo
We will strive to achieve sustainable growth for the Group and increase our corporate value
Founded
129
years ago
(in 1893)
(in 1893)
Number of employees
(consolidated)
3,921
people
Number of our prescription formulations
129
of
total 148
total 148
Sales
end of March2022
129,546
million JPY
Domestic market share
Kampo formulation for prescription
over
80
%
Business development
Prescription Kampo formulations
88.1
%
PRODUCT & QUALITY
Creating diversified value through the business of Kampo and raw materials
To ensure a stable supply of high quality Kampo Products
NEWS ROOM
-
2022.08.05 News ReleaseTsumura Announces Revision of Earnings Forecast
-
2022.08.05 IR NewsConsolidated Financial Results for the First Quarter of the Term Ending March 31, 2023 (Under Japanese GAAP)
-
2022.08.05 IR NewsThe Fiscal Year Ended March 31, 2023,Supplementary Materials
-
2022.08.04 IR NewsFirst Quarter Business Results for Fiscal Year 2022（Conference Call）
-
2022.07.22 News ReleaseTsumura Announces Completion of Payment for Disposition of Treasury Shares for Performance-Based Stock Compensation
-
2022.06.29 News ReleaseTsumura Announces Disposition of Treasury Shares for Performance-Based Stock Compensation
-
2022.04.14Sustainability Vision & Long-Term Management Vision Presentation(with note)
-
2022.04.14Sustainability Vision & Long-Term Management Vision Presentation(Q&A Summary)
-
2022.04.01The Tsumura Group Sets Its Medium- to Long-Term Environmental Targets
-
2022.04.01Tsumura Human Rights Policy Established
-
2022.04.01Tsumura Procurement Policy Established
-
2022.03.29Sustainability content has been released
-
2022.08.05Tsumura Announces Revision of Earnings Forecast
-
2022.07.22Tsumura Announces Completion of Payment for Disposition of Treasury Shares for Performance-Based Stock Compensation
-
2022.06.29Tsumura Announces Disposition of Treasury Shares for Performance-Based Stock Compensation
-
2022.06.011st Medium-Term Management Plan (FY2022 - FY2024)
-
2022.05.17Tsumura Announces Revision of Performance-Based Stock Compensation System
-
2022.05.17Notice Regarding Partial Amendment of the Articles of Incorporation
-
2022.08.05Consolidated Financial Results for the First Quarter of the Term Ending March 31, 2023 (Under Japanese GAAP)
-
2022.08.05The Fiscal Year Ended March 31, 2023,Supplementary Materials
-
2022.08.04First Quarter Business Results for Fiscal Year 2022（Conference Call）
-
2022.06.29The 86th Ordinary General Meeting of Shareholders was held
-
2022.06.03Notice of the 86th Ordinary General Meeting of Shareholders
-
2022.05.27Business Results for Fiscal Year 2021 Q&A Summary
